AI assistant
Anteris Technologies Global Corp. — Capital/Financing Update 2018
Jul 8, 2018
33869_rns_2018-07-08_c6fbeefb-51cc-42fa-a0d2-b20900e9c4f4.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
09/07/18
==> picture [451 x 24] intentionally omitted <==
ASX ANNOUNCEMENT
ASX Market Announcements Australian Securities Exchange Limited 10th Floor, 20 Bridge Street SYDNEY NSW 2000
ADMEDUS SIGNS NEW DISTRIBUTION AGREEMENT FOR ITALY
Admedus Limited (ASX:AHZ) is pleased to announce that it has signed an exclusive distribution agreement with Medical Instruments S.p.A. (Medical Instruments) to market and distribute its clinically-superior ADAPT® technology in Italy.
Under the agreement, Medical Instruments will initially distribute Admedus’ non-toxic and non-calcifying flagship ADAPT® bio-scaffold CardioCel® for the treatment of congenital and structural heart defects and disease.
Admedus Chief Operating Officer, David St Denis made today’s announcement,
“Admedus is delighted to partner with Medical Instruments to distribute our unique, worldleading technology to the patients and surgeons of Italy who have already shown keen interest and adoption of our ADAPT® products.”
“According to the World Health Organisation[1] , cardiovascular disease causes more than half of all deaths across Europe, causing 46 times the number of deaths and 11 times the disease burden caused by AIDS, tuberculosis and malaria combined in Europe. This creates an enormous need, and opportunity, for the type of innovative health solutions and technology that Admedus is focused on delivering.”
“Through our partnership with Medical Instruments, who have more than 40 years of demonstrated experience and success in the Italian medical device industry, we anticipate solid growth and development in this key market.”
Admedus Limited
Registered Office: Level 9, 301 Coronation Drive, Milton, Queensland 4064
Customer Service:
T: 1300 550 310 F: 1300 880 398 International: T: +61 (0)7 3152 3200 F: +61 (0)7 3152 3299 E: [email protected] W: admedus.com
==> picture [72 x 72] intentionally omitted <==
Brisbane • Minneapolis • Geneva • Singapore
ABN 35 088 221 078
Mr Marco Menarini of Medical Instruments also welcomed the new agreement,
“Medical Instruments S.p.A. is a dynamic and growing company that specialises in the fields of cardiac surgery, vascular surgery, interventional radiology and haemodynamics. We are proud to welcome Admedus and its outstanding ADAPT® technology to our portfolio as we strive to ensure Italian patients and physicians have access to the best possible resources and health outcomes.”
The distribution agreement is effective immediately.
ENDS
About Admedus Limited
Admedus (ASX:AHZ) is a medical technologies company delivering clinically superior solutions that help healthcare professionals create life-changing outcomes for patients. Our focus is on investing in and developing next generation technologies with world class partners, acquiring strategic assets to grow product and service offerings and expanding revenues from our existing medical sales and distribution business. The company has assets from research & development through clinical development as well as sales, marketing and distribution.
Website: www.admedus.com
Facebook: www.facebook.com/Admedus Twitter: @Admedus
For more information, please contact:
Admedus Limited Barbara Ferres
Communications Manager +61 7 3152 3216
==> picture [21 x 19] intentionally omitted <==